Concepedia

David Cheng

DC

Statistics

Publications

42

Citations

3.7K

H-Index

33

Active since

1997

Affiliations

University of California, Irvine(Current)

UNSW Sydney

Neuroscience Research Australia

University of Wollongong

Illawarra Health and Medical Research Institute

David Cheng is an author at University of California, Irvine specializing in neuroscience, neurodegenerative diseases, and neurodegenerative disorders.

ORCID

Publications per year

1997–2022

42

Publications

42

Blocking IL-1 Signaling Rescues Cognition, Attenuates Tau Pathology, and Restores Neuronal β-Catenin Pathway Function in an Alzheimer’s Disease Model

Masashi Kitazawa, David Cheng, Michelle R. Tsukamoto et al. · The Journal of Immunology · 2011 · 451 citations · Full text

, , +17

Deletion of<i>Abca7</i>Increases Cerebral Amyloid-β Accumulation in the J20 Mouse Model of Alzheimer's Disease

Woojin S. Kim, Hongyun Li, Kalani Ruberu et al. · Journal of Neuroscience · 2013 · 206 citations · Full text

, , +17

Inflammation Induced by Infection Potentiates Tau Pathological Features in Transgenic Mice

Michael Sy, Masashi Kitazawa, Rodrigo Medeiros et al. · American Journal Of Pathology · 2011 · 205 citations · Full text

, , +14

Long-Term Cannabidiol Treatment Prevents the Development of Social Recognition Memory Deficits in Alzheimer's Disease Transgenic Mice

David Cheng, Adena S. Spiro, Andrew M. Jenner et al. · Journal of Alzheimer s Disease · 2014 · 189 citations

, , +15

Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice

David Cheng, Jac Kee Low, Warren Logge et al. · Psychopharmacology · 2014 · 174 citations

, , +15

1–5 of 42